-
-
-
-
-
-
-
Lilly reports second-quarter 2026 financial results, raises full-year guidance, and highlights continued growth and pipeline progress
-
-
-
-
-
-
-
Lilly completes acquisition of Centessa Pharmaceuticals
-
-
-
-
-
-
-
Lilly announces three acquisitions to build infectious disease portfolio
-
-
-
-
-
-
-
Lilly to acquire Ajax Therapeutics for up to $2.3 billion
-
-
-
-
-
-
-
Eli Lilly & Co. (LLY) nears deal to acquire Kelonia Therapeutics - WSJ
-
-
-
-
-
-
-
Lilly gets FTC clearance for Innovent Biologics acquisition
-
-
-
-
-
-
-
Abivax shares surge after report flags continued Eli Lilly takeover interest
-
1,192,375 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

